Weight loss results from an energy deficit, although the quality of food choices making up the diet may also be important. The aim of the present study was to develop and validate a diet quality tool based on food categories to monitor dietary change in clinical weight-loss settings. The Food Choices Score (FCS) was based on seventeen food categories, each scoring up to five points, totalling 85. In addition to content validity, the tool was validated using (1) two energy-deficit diet models (6500 and 7400 kJ) assuring nutrient and food-group targets and (2) dietary data from two weight-loss trials (n 189). First, the diet models confirmed that an optimal score of 85 was achievable. Second, change in scores was compared with weight loss achieved at 3 months. The trial data produced a mean FCS of 42·6 (sd 8·6), increasing to 49·1 (sd 7·6) by 3 months. Participants who lost weight achieved a higher FCS at 3 months than those who did not (P= 0·027), and there was an even greater improvement in the FCS (P= 0·024) in participants losing ≥ 5 % body weight than in those losing < 5 %. A greater change in the FCS (Δ ≥ 7) resulted in a greater change in BMI (P =0·044), and score change was correlated with weight change (P= 0·023). Participants with the highest scores ( ≥ 56 v. ≤ 44/85) consumed more fruit (P< 0·001) and low-fat dairy foods (P =0·004), less fatty meat (P< 0·001), non-whole-grain cereals (P< 0·001), non-core foods and drinks (NCFD) (P< 0·001), less energy (P =0·018), less dietary fat (P< 0·001) and more dietary fibre (P= 0·013). Weight loss was 35·5 % less likely to be achieved with every increase in the serves of NCFD (P =0·004) in the study sample. The FCS is a valid tool for assessing diet quality in clinical weight-loss settings.

The massive use of air gaps in tooling, per the Evisto® concept, can confine the heatcontributed by the cast alloy in a small volume. The resulting high die wall temperaturesare turned to account to cast parts having ultra-thin walls, of the order of onemillimetre thick. Effective thermal insulation limits thermal exchanges to slow thecooling of a cast alloy. The property that best characterizes this effectiveness is thereciprocal of thermal conductivity, thermal resistance. Air was chosen as the insulatingmaterial because of its many advantages: very favourable thermal conductivity, limitedapplication cost, and zero purchase cost. Evisto®, an innovative tooling design, hasbeen used to produce plates 1 mm thick measuring 130 by 200 mm and automobile seat backs1.2 mm thick measuring 390 by 576 mm. The mechanical properties of the castings soproduced complied with standard EN 1706 of May 2010 for aluminium alloy castings. A patentapplication was filed for the Evisto®concept in August 2010.

In therapy of the metabolic syndrome, the optimal dietary approach with regard to its macronutrient composition and metabolically favourable food components, such as the plant-derived n-3 fatty acid α-linolenic acid (ALA), is still a matter of debate. We investigated the effects of a hypoenergetic diet with low energy density (ED) enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3·5 g/d on body weight and cardiovascular risk profile in eighty-one patients with the metabolic syndrome in comparison with an olive oil diet rich in MUFA, but with a low ALA content. After a 6-month dietary intervention, body weight was significantly reduced in the rapeseed oil and olive oil groups ( − 7·8 v. − 6·0 kg; P < 0·05). There were significant decreases in systolic blood pressure, total cholesterol and LDL-cholesterol, and insulin levels in both groups (P < 0·05). For all of these changes, no inter-group differences were observed. After the rapeseed oil diet, diastolic blood pressure declined more than after the olive oil diet (P < 0·05 for time × group interaction). Furthermore, concentrations of serum TAG were significantly reduced after the high ALA intake, but not in the low ALA group (P < 0·05 for time × group interaction). In conclusion, our dietary food pattern with a low ED and high intakes of MUFA and ALA may be a practical approach for long-term dietary treatment in patients with the metabolic syndrome, leading to weight reduction and an improvement in the overall cardiovascular risk profile.

Prevention of hypertension, and control of blood pressure in patients with hypertension, are necessary for the reduction of cardiovascular morbidity and mortality. Lifestyle modifications are one of the most important tools for effective lowering of blood pressure. Most randomized controlled studies have shown that even a modest weight loss of 3–9 % is associated with a significant reduction in systolic and diastolic blood pressure of roughly 3 mm Hg in overweight people. Limitation of sodium chloride in food has historically been considered the critical change for reducing blood pressure. Changes in sodium intake do affect blood pressure in older persons and in patients with hypertension and diabetes, whereas its role in population blood pressure has proven controversial. Recent meta-analyses indicate that adequate intake of minerals, e.g. potassium and probably calcium, rather than restriction of sodium, should be the focus of dietary recommendations. Although epidemiological data point to a direct relation between the intake of saturated fat, starch and alcohol, as well as an inverse relationship to the intake of omega-3 fatty acids and protein, our knowledge about macronutrients and blood pressure is scanty. It may well prove more productive to look at food instead of placing emphasis on single nutrients. Thus the Dietary Approaches to Stop Hypertension (DASH) demonstrates that a diet rich in fruits, vegetables, low-fat dairy products, fibre and minerals (calcium, potassium and magnesium) produces a potent antihypertensive effect. Such a diet is not very restrictive and should not produce compliance problems. Further high-quality research on the influence of macronutrients and food will yield data for updated recommendations, enabling better prevention and control of the blood pressure problem.